Sarcopenic Obesity in Neurodisabilities

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

June 15, 2021

Study Completion Date

May 15, 2022

Conditions
Sarcopenic ObesitySpinal Cord InjuriesStrokeMultiple SclerosisTraumatic Brain Injury
Interventions
DIAGNOSTIC_TEST

whole body DXA

Measurements of body composition may be used to study how lean body mass and body fat change during health and disease and have provided a research tool to study the metabolic effects of obesity and various wasting conditions. DXA measurements are based in part on the assumption that the hydration of fat-free mass remains constant at 73%.

Trial Locations (1)

13122

National Rehabilitation Center EKA, Nea Liosia

All Listed Sponsors
collaborator

University of Athens

OTHER

collaborator

University of Patras

OTHER

lead

Dionyssiotis, Yannis, M.D.

INDIV

NCT03863379 - Sarcopenic Obesity in Neurodisabilities | Biotech Hunter | Biotech Hunter